AVAXZIPEN Trademark
Trademark Overview
On Friday, March 31, 2023, a trademark application was filed for AVAXZIPEN with the United States Patent and Trademark Office. The USPTO has given the AVAXZIPEN trademark a serial number of 79388905. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 3, 2024. This trademark is owned by AVAXZIPEN LIMITED. The AVAXZIPEN trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances, namely for the treatment of infectious and autoimmune diseases; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of infectious and autoimmune diseases; biological, chemical and biochemical reagents for medical use; contraceptive preparations and substance...
Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, injection and infusion devices for administering pharmaceutical, biopharmaceutical and veterinary preparations; drug delivery devices sold empty, namely, injection devices; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devices, namely, drug cassettes sold empty; drug delivery devices, namely medical injectors, needle-free in...
Medical and veterinary research and product development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; Product development of pharmaceutical and biopharmaceutical delivery systems; Pharmaceutical and biopharmaceutical product development, namely research and formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; Product testing services for medical and veterinary devices and products; provision of information relating to product development and testing; Consulting services in the field of product development and testing
General Information
| Serial Number | 79388905 |
| Word Mark | AVAXZIPEN |
| Filing Date | Friday, March 31, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances, namely for the treatment of infectious and autoimmune diseases; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of infectious and autoimmune diseases; biological, chemical and biochemical reagents for medical use; contraceptive preparations and substances, namely, oral, chemical and parenteral based contraceptives |
| Goods and Services | Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, injection and infusion devices for administering pharmaceutical, biopharmaceutical and veterinary preparations; drug delivery devices sold empty, namely, injection devices; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devices, namely, drug cassettes sold empty; drug delivery devices, namely medical injectors, needle-free injectors, injectors with needles, all sold empty; drug delivery devices, sold empty, namely, medical injectors, needle-free injectors and parts and fittings therefore; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; pre-loaded drug cassettes for use in drug delivery devices to contain pharmaceutical and biopharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; Structural parts and fittings for all the aforesaid goods |
| Goods and Services | Medical and veterinary research and product development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; Product development of pharmaceutical and biopharmaceutical delivery systems; Pharmaceutical and biopharmaceutical product development, namely research and formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; Product testing services for medical and veterinary devices and products; provision of information relating to product development and testing; Consulting services in the field of product development and testing |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 12, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AVAXZIPEN LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | AVAXZIPEN LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Monday, February 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 12, 2024 | ASSIGNED TO EXAMINER |
| Friday, February 16, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 25, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, September 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 9, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 1, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, March 2, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, March 25, 2024 | REFUSAL PROCESSED BY MPU |
| Tuesday, April 16, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, September 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
